Dicot Pharma Dicot Pharma
  • The Pharmaceutical Project
    • The drug candidate LIB-01
    • Sexual dysfunctions
    • The Market
    • Patent
    • Publications
    • Advisory expert group
  • About Dicot Pharma
    • Business idea, strategy & vision
    • Management
    • Board
    • Background
    • Contact
  • Media
    • Articles
    • Films
    • Podcasts
    • DICOTnews
  • Press
    • Press Releases
    • Press Images
  • Investor Relations
    • The share
    • Corporate governance
    • Reports and issues
    • Financial calendar and events
    • Analysis
    • Subscribe
  • Subscribe
  • The Pharmaceutical Project
    • The drug candidate LIB-01
    • Sexual dysfunctions
    • The Market
    • Patent
    • Publications
    • Advisory expert group
  • About Dicot Pharma
    • Business idea, strategy & vision
    • Management
    • Board
    • Background
    • Contact
  • Media
    • Articles
    • Films
    • Podcasts
    • DICOTnews
  • Press
    • Press Releases
    • Press Images
  • Investor Relations
    • The share
    • Corporate governance
    • Reports and issues
    • Financial calendar and events
    • Analysis
    • Subscribe
  • Subscribe
  • På svenska
På svenska
  • Home/
  • Press/
  • Press Releases

Dicot Pharma is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs.

Follow us on linkedIn  

Dicot Pharma AB
S:t Olofsgatan 11A
SE-753 21 Uppsala
SWEDEN

+46 72 502 10 10
info@dicotpharma.com

© Copyright Dicot Pharma AB.
All rights reserved.

Change settings for cookies

Integrity policy and GDPR

Annual report 2024

Annual Report 2024

Our website uses cookies to improve your experience and for targeted marketing.
By closing this information you consent to our use of cookies. You can configure and read more about cookies on dicotpharma.com here.

Accept all